Organization · Venture Capital
Quantum Group Investment Management
Quantum Group Investment Management is an Australia-based investment management firm specializing in early to mid-stage medical technologies, particularly in cardiovascular, respiratory, and chronic disease sectors. The firm focuses on innovative solutions that address significant healthcare gaps and enhance patient care.
Overview
What Quantum Group Investment Management does
What Quantum Group Investment Management is
Quantum Group Investment Management is an Australia-based investment management firm specializing in early to mid-stage medical technologies, particularly in cardiovascular, respiratory, and chronic disease sectors. The firm focuses on innovative solutions that address significant healthcare gaps and enhance patient care.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Quantum Group Investment Management elsewhere
Open the official website or a supported primary organization account.
Capability profile
Quantum Group Investment Management as a funder
Investment thesis
Quantum's investment thesis focuses on addressing large unmet clinical needs in cardiovascular, respiratory, and chronic disease markets through innovative medical technologies that improve patient outcomes and have clear pathways to regulatory approval.
Focus narrative
Quantum focuses on investing in early to mid-stage medical technologies that demonstrate significant innovation and have a total addressable market exceeding $500 million. The firm emphasizes technologies with clear pathways to regulatory approval and typically allocates between $15 million to $20 million per company.
Value beyond capital
Quantum adds value to its portfolio companies by offering active post-investment support, including commercial expertise and access to a network of medical and capital-markets advisors. This hands-on approach helps portfolio companies navigate the complexities of bringing innovative medical technologies to market.
Terms and economics
- Typical check
- $15,000,000–$20,000,000
Focus and fit
- Stages
- Seed · Seed+ · Series A · Series A+
- Regions
- Global · Oceania
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 50
Portfolio context
Quantum has reviewed over 100 proprietary technologies, with more than 50 currently in its pipeline. Specific portfolio companies are not disclosed, but the firm actively manages its investments, providing commercial expertise and support services to aid in their development and market implementation.
Common questions
What to know about Quantum Group Investment Management
Upseed classifies Quantum Group Investment Management under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.